This opinion cited by 24 cases:
In Re Accelr8 Technology Corp. Securities Litigation , 147 F. Supp. 2d 1049 ( 2001 )
Securities & Exchange Commission v. Kokesh , 834 F.3d 1158 ( 2016 )
Kunz v. Securities & Exchange Commission , 64 F. App'x 659 ( 2003 )
Securities & Exchange Commission v. Merrill Scott & Associates, Ltd. , 505 F. Supp. 2d 1193 ( 2007 )
Securities & Exchange Commission v. Nacchio , 704 F. Supp. 2d 1099 ( 2010 )
Adell v. John Richards Homes Building Co. (In Re John Richards Homes Building Co.) , 52 Collier Bankr. Cas. 2d 1125 ( 2004 )
In Re Ribozyme Pharmaceuticals, Inc. Securities Litigation , 209 F. Supp. 2d 1106 ( 2002 )
United States v. Dowlin , 408 F.3d 647 ( 2005 )
Abbott v. Equity Group, Inc. , 2 F.3d 613 ( 1993 )
GENERAL BOND & SHARE CO., Petitioner, v. SECURITIES AND EXCHANGE COMMISSION, Respondent , 39 F.3d 1451 ( 1994 )
Rooms v. Securities & Exchang ( 2006 )
Michael A. Rooms v. Securities and Exchange Commission , 444 F.3d 1208 ( 2006 )
fed-sec-l-rep-p-90197-98-cal-daily-op-serv-3143-98-daily-journal , 142 F.3d 1186 ( 1998 )
96-cal-daily-op-serv-9137-96-daily-journal-dar-15131-diane-provenz , 102 F.3d 1478 ( 1996 )
fed-sec-l-rep-p-97772-walter-r-abbott-md-and-mrs-e-elizabeth , 2 F.3d 613 ( 1993 )
United States v. Armstrong , 116 S. Ct. 1480 ( 1996 )
Gomez v. Huntington Trust Co., NA , 129 F. Supp. 2d 1116 ( 2000 )
Malouf v. SEC. & Exch. Comm'n , 933 F.3d 1248 ( 2019 )
Layng v. Rael ( 2018 )
Bormann v. Applied Vision Systems, Inc. , 800 F. Supp. 800 ( 1992 )
